Suramin potently inhibits binding of the mammalian high mobility group protein AT-hook 2 to DNA

L Su, N Bryan, S Battista, J Freitas, A Garabedian… - BioRxiv, 2019 - biorxiv.org
… Since suramin has strong antitumor and anti-metastasis … The second type of two suramin
binding sites has a binding … -stranded DNA breaks through topoisomerase II poisoning. A …

Structure-activity relationship and synthetic methodologies of α-santonin derivatives with diverse bioactivities: A mini-review

J Wang, S Su, S Zhang, S Zhai, R Sheng, W Wu… - European Journal of …, 2019 - Elsevier
… effects such as liver and kidney toxicity, mental disorders, etc. … santonin derivatives for
discovering novel therapeutic agents … (Eflornithine and Suramin) with EC 50 of antitrypanosomal …

Novel anticancer agents in clinical development

AA Adjei, EK Rowinsky - Cancer biology & therapy, 2003 - Taylor & Francis
… Most therapeutic agents have been developed empirically by … Suramin is a macromolecule
that binds to a number of … dispersion of epithelial cells (HT-29 colon cancer cells) induced …

[HTML][HTML] Influence of Levamisole and Other Angiogenesis Inhibitors on Angiogenesis and Endothelial Cell Morphology in Vitro

T Friis, AM Engel, CD Bendiksen, LS Larsen, G Houen - Cancers, 2013 - mdpi.com
… found to be more potent and less toxic than fumagillin [61,62,63,… Suramin has been
demonstrated to influence angiogenesis … treatment for patients with colorectal cancer and lung …

Inhibition of granulocyte-macrophage colony-stimulating factor (GM-CSF) activity by suramin and suramin analogues is correlated to interaction with the GM-CSF …

M Doukas, A Chavan, C Gass, P Nickel, T Boone… - Cancer research, 1995 - AACR
Double screening of suramin derivatives on human colon cancer cells and on neural
cells provides new therapeutic agents with reduced toxicity. …

[PDF][PDF] Targeting heparanase in cancer: inhibition by synthetic, chemically modified, and natural compounds

CD Mohan, S Hari, HD Preetham, S Rangappa… - Iscience, 2019 - cell.com
Suramin failed to advance into clinical trials owing to its toxicity including adrenal insufficiency,
renal toxicity, … the design and optimization of heparanase inhibitors as therapeutic agents

Fibroblast growth factors and their inhibitors

F Manetti, F Corelli, M Botta - Current pharmaceutical design, 2000 - ingentaconnect.com
… adult brain and testis, and in human colon carcinoma cell lines [58]. Recently, suramin (1) has
… an anabolic effect in bone, suggesting this protein as a potentially useful therapeutic agent

2-Amino-1, 3, 4-thiadiazoles as prospective agents in trypanosomiasis and other parasitoses

G Serban - Acta Pharmaceutica, 2020 - hrcak.srce.hr
… of megazol with suramin or melarsoprol in the treatment of T. brucei … therapeutic agents,
as well as the control of parasite … aminothiadiazole in advanced colorectal cancer. An Illinois …

Glycosyl and alkyl modifications on potential therapeutic drugs targeting parasitic, cancer and neurodegenerative diseases

E Belmonte Reche - 2018 - digibug.ugr.es
… the commonly used drugs used to treat the disease such as Suramin and … toxic in cancer
cells than the aglycone and 6 times less toxic in mice.[110] 18fluoro-2-deoxyglucose (FDG) has

HuR-targeted agents: an insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models

G Assoni, V La Pietra, R Digilio, C Ciani… - Advanced Drug Delivery …, 2022 - Elsevier
provideneuronal cells, from hepatocytes to adipose cells have further shown the exquisite
role of HuR in regulating many aspects of cellular differentiation and functions in various cell